Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.50 |
| ▸ | MAPT | P10636 | 4/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.50 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.47 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.47 |
| ▸ | GRK6 | P43250 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | EGFR | P00533 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10046157 | 0.86 | MAPT (0.52) | ALDH1A1MAPTMEN1KMT2ANPC1 | |
| SCHEMBL13306037 | 0.84 | ALDH1A1 (0.46) | ALDH1A1MAPTMEN1KMT2ANPC1 | |
| SCHEMBL13645995 | 0.83 | CYP2A6 (0.64) | ALDH1A1MAPTKMT2ACYP2A6CYP2A13 | |
| SCHEMBL18994843 | 0.83 | ALDH1A1 (0.50) | ALDH1A1MAPTMEN1KMT2ANPC1 | |
| SCHEMBL4698122 | 0.82 | ALDH1A1 (0.55) | ALDH1A1MAPTMEN1KMT2ACYP2A6 | |
| SCHEMBL11331207 | 0.82 | CYP2A6 (0.53) | ALDH1A1MAPTMEN1KMT2ACYP2A6 | |
| SCHEMBL8722764 | 0.81 | ALDH1A1 (0.65) | ALDH1A1MAPTMEN1KMT2ACYP2A6 | |
| SCHEMBL9836517 | 0.81 | ALDH1A1 (0.53) | ALDH1A1MAPTMEN1KMT2ACYP2A6 | |
| SCHEMBL10046156 | 0.80 | ALDH1A1 (0.54) | ALDH1A1MAPTMEN1KMT2ANPC1 | |
| SCHEMBL13645975 | 0.80 | CYP2A6 (0.59) | ALDH1A1MAPTMEN1KMT2ACYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12235217-B2 | Diagnostic test kits for sample preparation and analysis | SCANWELL HEALTH, INC. (US) | 2025-02-25 | — | — | US | claimed |
| EP-4058775-A1 | DIAGNOSTIC TEST KITS FOR SAMPLE PREPARATION AND ANALYSIS | Scanwell Health, Inc. (US) | 2022-09-21 | — | — | EP | claimed |
| CN-114981637-A | Diagnostic test kit for sample preparation and analysis | 斯肯威尔健康公司 | 2022-08-30 | — | — | CN | claimed |
| US-12617812-B2 | Platinum(IV) complexes, methods of manufacture, compositions containing, and methods of use thereof | CITY UNIVERSITY OF HONG KONG (HK) | 2026-05-05 | — | — | US | disclosed |
| EP-4419206-B1 | COMPOUNDS FOR THE TREATMENT OF MALARIA | FUNDACIO INST DE BIOENGINYERIA DE CATALUNYA (ES) | 2025-09-17 | — | — | EP | disclosed |
| US-20250258104-A1 | DIAGNOSTIC TEST KITS FOR SAMPLE PREPARATION AND ANALYSIS | SCANWELL HEALTH INC (US) | 2025-08-14 | — | — | US | disclosed |
| US-12235217-B2 | Diagnostic test kits for sample preparation and analysis | SCANWELL HEALTH, INC. (US) | 2025-02-25 | — | — | US | disclosed |
| US-20240415825-A1 | COMPOUNDS FOR THE TREATMENT OF MALARIA | Fundación Privada Instituto De Salud Global Barcelona (ES) | 2024-12-19 | — | — | US | disclosed |
| EP-4419206-A1 | COMPOUNDS FOR THE TREATMENT OF MALARIA | Fundacio Institut de Bioenginyeria de Catalunya (ES) | 2024-08-28 | — | — | EP | disclosed |
| CN-118475559-A | Compounds for malaria treatment | 加泰罗尼亚生物工程基金会研究所 | 2024-08-09 | — | — | CN | disclosed |
| US-11730055-B2 | Dopant, charge transfer salt and organic electronic device | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2023-08-15 | — | — | US | disclosed |
| EP-0092698-A1 | Process for the preparation of cationic methine dyes | BAYER AG (DE) | 1983-11-02 | — | — | EP | disclosed |
| US-4396767-A | COLORS, CARBONLESS DUPLICATION | STERLING DRUG INC. (US) | 1983-08-02 | — | — | US | disclosed |
| US-4389474-A | Thiopyrylium compounds and photoconductive compositions containing said compounds | FUJI PHOTO FILM CO., LTD. (JP) | 1983-06-21 | — | — | US | disclosed |
| EP-0074569-A2 | Cationic methine dyes, process for their preparation and their use, in dyeing textile materials and other substrates | BAYER AG (DE) | 1983-03-23 | — | — | EP | disclosed |
| US-4363503-A | FOR PRESSURE SENSITIVE CARBONLESS DUPLICATING AND THERMAL MARKING SYSTEMS | STERLING DRUG INC. (US) | 1982-12-14 | — | — | US | disclosed |
| EP-0061128-A1 | Pyridine compounds, process for their preparation and systems containing them | STERLING DRUG INC. (US) | 1982-09-29 | — | — | EP | disclosed |
| US-3975379-A | METHINE | BAYER AKTIENGESELLSCHAFT (DT) | 1976-08-17 | — | — | US | disclosed |
| US-3962220-A | ONE-STEP, AROMATIC ALDEHYDES, ACETIC ACID | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-06-08 | — | — | US | disclosed |
| US-3962221-A | CONDENSATION, REDUCTION, OXIDATION | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240415825-A1 | COMPOUNDS FOR THE TREATMENT OF MALARIA | ABAT, GLS2, CPS1 | ALDH1A1 2819/4885MAPT 24/4885MEN1 1686/4885 |
| US-11730055-B2 | Dopant, charge transfer salt and organic electronic device | CHRM1, SLC6A3, DRD1 | ALDH1A1 1969/4885MAPT 1286/4885MEN1 269/4885 |
| US-12617812-B2 | Platinum(IV) complexes, methods of manufacture, compositions containing, and methods of use thereof | OGDH, C9, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | ALDH1A1 569/4885MAPT 4191/4885MEN1 1033/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.